PBI-Gordon Companies, Inc., an organization that inspires innovations for green spaces, pets, and people, announces the strategic acquisition of TriviumVet®, a leading research and development company advancing innovative treatments for chronic conditions in cats and dogs. The move is the largest transaction in the company's 77-year history and includes the addition of an innovative new product, Felycin®-CA1, to the PRN® Pharmacal portfolio of products.